Benefits Broker

Ozempic, Trulicity and Mounjaro were first approved to treat diabetes, however, in the last three years, the FDA has approved rebranded versions of Mounjaro and Ozempic for weight loss, leading demand – and prices – to skyrocket.

After three years, only a third of 2,000 U.S. hospitals reviewed were in compliance with the Hospital Price Transparency Rule of 2021, says a new PRA report, which puts some of the blame on feds for not enforcing the rule.

We're joined by Daniel Cobb, Vice President of Sales and Strategy at Strategic Benefit Resources, to discuss the evolving landscape of stop-loss self-funding and the tech and data solutions supporting it.

Construction, notably, is the happiest industry and the only one to boast an eNPS over 50.

At a Senate Judiciary Committee hearing, Senators accused drugmakers of gaming the system by filing 100+ patents for any given drug, while trade group PhRMA said the system advances "the development of new medicines."

NPs often perform the same tasks that patients have relied on doctors for, however, only 30% are going into primary care and instead joining cardiology, dermatology, and other specialty practices, and increasing their income.

Here is a deeper look at five areas where automated employee benefits can reap rewards for employers and their workforce and where benefits advisors can help guide change.

While access to mental health services is a problem for just about everyone, everywhere, the LGBTQ+ community is facing a dangerous trifecta — cultural and political volatility, an accelerating mental health crisis, and an inequitable healthcare system — that needs immediate and sustained action.